Low-Level use of Testosterone in Women as a PED 101

An introduction to Testosterone elevation in Women for Performance Enhancing Outcomes


Study data shows

1, As determined by tandem mass spectrometry, the normal female range of circulating testosterone is 0.1–1.8 nmol/L and does not overlap with the normal male range (7.7–29.4 nmol/L).

2 The dose used resulted in an increase in mean serum testosterone of 4.3 nmol/L, which is clearly below the male range, and yet increased some indices of performances.

Click to enlarge image

3, The IAAF requires that athletes with naturally produced high testosterone and normal androgen receptor sensitivity reduce their testosterone level to <5 nmol/L to be eligible to compete in the female category at the international level in middle distance race.

So you can compete as a Natural Women with T levels greater than what is realized from exposure to 10mg T cream a day


48 healthy, physically active women aged 18–35 years were randomised to 10 weeks of treatment with 10 mg of testosterone cream daily or placebo (1:1)

Participants were randomly assigned to treatment with placebo cream (1 mL) or testosterone cream 10 mg (1 mL) (Andro-Feme 1) applied every evening to the upper outer thigh for 10 weeks.

Serum levels of testosterone increased from 0.9 (0.4) nmol/L to 4.3 (2.8) nmol/L in the testosterone supplemented group.

Safety and adverse events

Adverse events were documented in 16 and 7 subjects in the testosterone and placebo groups, respectively. In the testosterone group, 58{2658607c068490114260e14c260e6ae174f4b10b752c604f4a58b348bf83bb16} of the women reported increased acne compared with 25{2658607c068490114260e14c260e6ae174f4b10b752c604f4a58b348bf83bb16} in the placebo group.

Five and four women showed increased body hair growth in the testosterone and placebo groups, respectively. One woman in each group had an increased Ferriman–Gallwey score, indicating hirsutism.

Furthermore, menstrual disturbances (ie, prolonged cycles) were reported by four individuals in the testosterone group. All of these adverse events returned to normal 4 months after study completion.

Victor Black